Works by Kim, Seok


Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.

    Published in:
    Cancer Science, 2010, v. 101, n. 11, p. 2443, doi. 10.1111/j.1349-7006.2010.01698.x
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Jin Seok;
    • Kim, Seok Jin;
    • Lee, Suee;
    • Lee, Dae Ho;
    • Won, Jong-Ho;
    • Hwang, In Gyu;
    • Kim, Min Kyoung;
    • Lee, Soon Il;
    • Chae, Yee Soo;
    • Yang, Deok-Hwan;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Park, Jinny;
    • Kim, Hyo Jung;
    • Kwon, Jung Hye;
    • Lee, Ho Sup;
    • Lee, Gyeong-Won;
    • Eom, Hyeon Seok
    Publication type:
    Article
    17
    18
    19

    Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 4, p. 413, doi. 10.1002/ajh.25726
    By:
    • Ho Sup Lee;
    • Kihyun Kim;
    • Seok Jin Kim;
    • Je-Jung Lee;
    • Inho Kim;
    • Jin Seok Kim;
    • Hyeon-Seok Eom;
    • Dok Hyun Yoon;
    • Cheolwon Suh;
    • Ho-Jin Shin;
    • Yeung-Chul Mun;
    • Min Kyoung Kim;
    • Sung-Nam Lim;
    • Chul Won Choi;
    • Hye Jin Kang;
    • Sung-Soo Yoon;
    • Chang-Ki Min
    Publication type:
    Article
    20

    Relapsed or refractory nongastric marginal zone B-cell lymphoma: Multicenter retrospective analysis of 92 cases.

    Published in:
    American Journal of Hematology, 2009, v. 84, n. 12, p. 826, doi. 10.1002/ajh.21557
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Seok Jin;
    • Kim, Jin Seok;
    • Kim, Sung-Hyun;
    • Lee, Dae Ho;
    • Won, Jong-Ho;
    • Hwang, In Gyu;
    • Kim, Min Kyoung;
    • Lee, Soon Il;
    • Kim, Jong Gwang;
    • Yang, Deok-Hwan;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Park, Jinny;
    • Choi, Young Jin;
    • Kim, Hyo Jung;
    • Kwon, Jung Hye;
    • Suh, Cheolwon;
    • Kim, Hyo-Jin
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 6, p. 1406, doi. 10.3109/10428194.2015.1099650
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Jin Seok;
    • Chae, Yee Soo;
    • Lee, Gyeong-Won;
    • Eom, Hyeon Seok;
    • Ryoo, Hun Mo;
    • Lee, Suee;
    • Kim, Seok Jin;
    • Yoon, Dok Hyun;
    • Won, Jong Ho;
    • Hong, Junshik;
    • Park, Jinny;
    • Lee, Sang-Min;
    • Hong, Jung Yong;
    • Park, Eunkyung;
    • Kim, Hyo Jung;
    • Yang, Deok-Hwan;
    • Kim, Hyo-Jin;
    • Suh, Cheolwon
    Publication type:
    Article
    37

    Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 4, p. 1020, doi. 10.3109/10428194.2014.946027
    By:
    • Lee, Gyeong-Won;
    • Go, Se-Il;
    • Kim, Seok-Hyun;
    • Hong, Junshik;
    • Kim, Yu Ri;
    • Oh, Sukjoong;
    • Kim, Sung-Yong;
    • Do, Young Rok;
    • Lee, Hyewon;
    • Lee, Soon Il;
    • Bae, Sung Hwa;
    • Oh, Sung Yong;
    • Song, Moo Kon;
    • Lee, Won-Sik;
    • Lee, Bohee;
    • Kim, Jin Seok;
    • Kim, Min Kyoung;
    • Kang, Hye Jin;
    • Ahn, Jae-Sook;
    • Yhim, Ho-Young
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50